How much funding has Arcam AB raised?

Arcam AB has raised $724M in total funding. Key investors include European Union.

Who is the CEO of Arcam AB?

Alexander Lee is the CEO of Arcam AB. The company was founded in 1997.

Where is Arcam AB located?

Arcam AB is headquartered in Mölndal, Sweden.

What funding stage is Arcam AB at?

Arcam AB is currently at the Acquired stage.

How many employees does Arcam AB have?

Arcam AB has approximately 201-500 employees.

Arcam AB

Name: AM Companies Database
Creator: AMPulse
License: https://creativecommons.org/licenses/by/4.0/

HardwareMölndal, SwedenFounded 1997· One of 1708 Hardware companies tracked by AMPulse

Arcam AB offers cost-efficient additive manufacturing solutions for producing complex metal components using Electron Beam Melting (EBM) technology.

CEO / Founder: Alexander Lee
Team Size: 201-500
Stage: Acquired
Total Funding: $724M
Latest Round: Acquired
Key Investors: European Union

Technology & Products

Key Products

Electron Beam Melting (EBM) systems (e.g., Q20), powder metals, and implant contract manufacturing.

Technological Advantage

Advanced EBM solutions that deliver high-quality, cost-effective metal component production.

Differentiation

Value Proposition

Provides cost-efficient production of complex metal components with enhanced design freedom through pioneering EBM technology.

How They Differentiate

Proprietary EBM technology offering distinct advantages in efficiency and part quality compared to competitors, particularly for aerospace and medical applications.

Market & Competition

Target Customers

Orthopedic and aerospace industries

Industry Verticals

["Aerospace","Medical"]

Competitors

Stratasys, Velo3D, 3D Systems Corporation, EOS, EnvisionTEC.

Growth & Milestones

Growth Metrics

Reported $88.22M in revenue with significant sales growth pre-acquisition

Major Milestones

["Development of EBM technology","Acquired by GE in 2017"]

Notable Customers

NASA, Airbus, Boeing, Lima, Adler Ortho, FIT (per Marketscreener company profile)

https://www.arcam.co.uk

Why this company matters

Arcam AB established Electron Beam Melting (EBM) as a production-grade metal additive manufacturing process, differentiating from laser-based powder bed fusion by using an electron beam to melt metal powder in a vacuum. This approach reduces residual stresses and enables faster build rates for certain geometries, positioning Arcam as a specialist in high-value, mission-critical parts rather than a generalist AM hardware vendor.

The company's core product line includes EBM systems such as the Q20, along with proprietary metal powders and contract manufacturing services for orthopedic implants. EBM operates at elevated temperatures, which minimizes post-process heat treatment and allows production of materials like Ti-6Al-4V and Inconel 718 with mechanical properties suited for load-bearing medical and aerospace applications.

Arcam's customer base spans orthopedic implant manufacturers such as Lima and Adler Ortho, and aerospace primes including NASA, Airbus, and Boeing. The medical segment relies on EBM for porous lattice structures that promote bone ingrowth, while aerospace uses the process for lightweight brackets and turbine components. The company was acquired by GE in 2017 and integrated into GE Additive, though its Swedish R&D operations continue to develop EBM technology.

The primary competitive risk to Arcam's EBM platform comes from laser-based LPBF systems offered by EOS, 3D Systems, and Velo3D, which have broader material ecosystems and larger installed bases. EBM's advantage in productivity for certain titanium parts is offset by its higher system cost and more limited material range. Arcam's long-term moat depends on continued adoption of EBM in orthopedic mass production and aerospace qualification programs.